News
StockStory.org on MSN23h
Bruker, agilon health, and AdaptHealth Shares Are Falling, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed ...
StockStory.org on MSN9d
Why Bruker (BRKR) Shares Are Getting Obliterated Today
What Happened? Shares of scientific instrument company Bruker (NASDAQ:BRKR). fell 13.8% in the afternoon session after the ...
Shares of Bruker fell after the company reported preliminary second-quarter results that missed Wall Street's expectations, hurt by what it called weak academic demand and a soft biopharma market in ...
View the latest Bruker Corp. (BRKR) stock price, news, historical charts, analyst ratings and financial information from WSJ.
8don MSN
Health Care Roundup: Market Talk
Find insight on Bruker, Sartorius, Sarepta and more in the latest Market Talks covering Health Care.
Bruker Corporation is a life-sciences company that has delivered returns of 20% annually for the last 15 years, comfortably beating the S&P 500. However, the share price has fallen -34% from its ...
SkyQuest Technology Consulting published a report, titled, Molecular Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2025-2032", valued at USD 19.1 Billion in 2024. With a ...
Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell ...
Bruker expects to right-size PhenomeX’s cost structure immediately and expects the acquisition of PhenomeX to be slightly dilutive to Bruker’s non-GAAP EPS in 2024 and 2025, and accretive to ...
Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell ...
Bruker Spatial Biology also plans to announce the extension of their collaboration with Weill Cornell Medicine on the Spatial Atlas of Human Anatomy (SAHA) initiative, to create multicellular ...
Bruker is down 40.2% since the beginning of the year, and at $35.16 per share, it is trading 50.2% below its 52-week high of $70.67 from September 2024. Investors who bought $1,000 worth of Bruker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results